Should the Rangers bring up Josh Hamilton’s substance abuse history if they go to arbitration?

25 Comments

Unless they settle with either a one-year deal or a big lockup package, Josh Hamilton and the Rangers are slated to head to an arbitration hearing sometime soon.  From that an interesting question emerges: how hard do the Rangers hit him — if they hit him at all — with his substance abuse history?

The immediate answer that comes to mind may be “none at all! How rude that would be!”  I get that, and as I’ll write below, I agree that they ultimately shouldn’t go there.  But arbitration is litigation and the litigation process is such that it’s really, really difficult to pull one’s punches.  And not just because of rudeness concerns, but because of precedent.

An arbitration doesn’t just set the current player’s salary. It’s used as a baseline for later players with similar production and similar service time who head into the process themselves. If one team eases up on Josh Hamilton, other teams heading into arbitration with their Hamiltonian super stars will have a tougher hill to climb in order to prevail.  In a way, then, the integrity of the process requires that the parties fight their hardest case possible.

And it’s not hard to see how Hamilton’s history could, theoretically, be used against him.  Not on moral grounds, per se, but because his drug use took away from many important development years. Hamilton has had an injury history.  If the Rangers want to argue that that history gives them pause, could they not — and should they not — point to Hamilton’s abnormal development as a player as a potential reason for concern?  Could they not also point to his brief and highly-publicized relapse in 2009 as an added risk factor with respect to future playing time?  Another relapse and — bam! — he’s in rehab. I’m not saying that they should do that, just that they could.

MLB Trade Rumors spoke with someone today who cautioned the Rangers on that front:

The Rangers could bring up Hamilton’s injury history and past substance abuse, but they would have to do so subtly, says Michael Vlessides, a veteran arbitration consultant.  “It’s the fine line between how much do you pick on the guy who’s the MVP. If you do it too much, you can lose a lot of credibility” Vlessides said. Beating MVPs in arbitration hearings isn’t easy, but the Pirates beat Barry Bonds after he won his first MVP in 1990 and again the following offseason.

I’ll go one better and say that trashing an MVP is not just a bad thing to do for credibility purposes, but that it’s a bad thing to do with Josh Hamilton and his drug history specifically for strategic purposes.

Why would Hamilton’s history be a detriment to his value?  Sure, it may be for many other players, but Hamilton is a unique case. That relapse notwithstanding, he’s turned his story into something of a fairytale. It’s triumph-over-adversity stuff, and if anything it has made him a much more popular player than he otherwise would be.  There’s value in that. Actual financial value to the Rangers that could make bringing the subject up worse for them than if they leave it alone.

Personally, I’d have a hard time seeing the Rangers go there. They’re not a dumb organization. Since Nolan Ryan took over, they seem to go out of their way to avoid ruffling their own players’ feathers, and I see no reason why they’d start with Hamilton.

But I also suspect that they know what Hamilton is all about, both as a player and as a phenomenon.  It’s not easy for baseball to bring totally new fans into the fold. People who wouldn’t otherwise pay attention.  If anyone has brought those kinds of fans into the game in the past couple of years, it’s Josh Hamilton, and I presume the Rangers are well aware of this.

Report: Dodgers sign Tom Koehler to one-year deal

Getty Images
Leave a comment

The Dodgers have reportedly agreed to a one-year deal with free agent right-hander Tom Koehler, per Chris Cotillo of SB Nation. The team has yet to officially announce the signing, which is currently pending a physical.

Following a mostly-productive five-year run with the Marlins, the 31-year-old flamed out in 12 starts for Miami in 2017, eventually coming over to the Blue Jays in a midseason trade for minor leaguer Osman Gutierrez. He made a successful transition to the bullpen and finished the season on a high note, pitching to a 2.65 ERA, 3.2 BB/9 and 9.5 SO/9 in 17 innings.

Koehler was non-tendered by the Blue Jays earlier this month and had attracted a fair amount of interest around the league prior to his signing. He’s expected to reprise his role as a middle reliever in Los Angeles, though Cotillo speculates that he could also bring some depth and balance to the Dodgers’ lefty-heavy rotation.